The North America high flow nasal cannula market is expected to reach US$ 4,261.14 Mn in 2027 from US$ 1,644.50 Mn in 2018. The market is projected to grow with a CAGR of 11.3% from 2019-2027.
The key factors that are driving the growth of the High-Flow Nasal Cannula market are increasing government initiatives and growing asthma cases. However, the factors restraining the market growth are adverse effects or risk of high flow nasal cannula.
Significant funding is provided to ensure that quality clinical research is conducted into chronic respiratory conditions, and to maintain national monitoring and surveillance measures. Programs that support the management and treatment of chronic respiratory conditions include The Medicare Benefits Schedule, The Pharmaceutical Benefits Scheme, and investments in arthritis research through the National Health and Medical Research Council (NHMRC) for research into chronic respiratory conditions. The agenda of these programs is to improve the care of patients with multiple and complex chronic diseases, including asthma and COPD. Funding has been provided to organizations such as Asthma Australia, the National Asthma Council, and the Lung Foundation.
According to the Centers for Disease Control and Prevention (CDC), COPD is the third leading cause of death in the United States. During the year 2013 to 2017, an estimated 2.4 million U.S. working adults aged above 18 years had COPD who never smoked. The highest COPD prevalence among non-smokers were in the information (3.3%) and mining (3.1%) industries and office and administrative support occupation workers (3.3%). Also, COPD prevalence are higher in women as compared to men. As pet the Office of Disease Prevention and Health Promotion (ODPHP), the burden of respiratory diseases affects not only the patients but also their families, children, and their nearby neighborhoods, cities, and states.
North America High-Flow Nasal Cannula Market – By Component
North America High-Flow Nasal Cannula Market – By Application
North America High-Flow Nasal Cannula Market – By End User
North America High Flow Nasal Cannula market
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 1,644.50 Million |
| Market Size by 2027 | US$ 4,261.14 Million |
| CAGR (2019 - 2027) | 11.3% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Component
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
The North America High-Flow Nasal Cannula Market is valued at US$ 1,644.50 Million in 2018, it is projected to reach US$ 4,261.14 Million by 2027.
As per our report North America High-Flow Nasal Cannula Market, the market size is valued at US$ 1,644.50 Million in 2018, projecting it to reach US$ 4,261.14 Million by 2027. This translates to a CAGR of approximately 11.3% during the forecast period.
The North America High-Flow Nasal Cannula Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America High-Flow Nasal Cannula Market report:
The North America High-Flow Nasal Cannula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America High-Flow Nasal Cannula Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America High-Flow Nasal Cannula Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America High-Flow Nasal Cannula Market
